Skip to NavigationSkip to content

Bayer UK unveils new Artificial Intelligence ‘LifeHub’

Published on 10/10/19 at 10:56am

Bayer has launched LifeHub UK as part of a network of global innovation hubs designed to accelerate and optimise disease detection and data-driven drug discovery by developing Artificial Intelligence-enabled imaging solutions.

The Reading-based hub is the newest member of Bayer’s growing family of LifeHubs located at global innovation hotspots, including Berlin, Boston, California, Lyon, Singapore and Japan. Sensyne Health will be one of the first companies to have a presence in the Bayer LifeHub UK.

The move itself is a part of the Bayer vision to leverage a global ecosystem of key technology partners to jointly create world leading AI and digital solutions in health and nutrition. Bayer has currently committed an investment of around £3 million in LifeHub UK with Sensyne Health to work in partnership with Bayer on novel projects.

Kemal Malik, Bayer Board Member for Innovation, said:  ”We are delighted to launch LifeHub UK. We firmly believe that Artificial Intelligence has transformative potential for healthcare, leading to enhancements in prediction, prevention and personalised treatments.”

Initially, LifeHub UK focus on the development of AI-enabled radiology solutions. Sensyne Health, the first to have a presence in LifeHub UK will continue to jointly accelerate the clinical development of new treatments with an initial focus on digital solutions for automated image evaluation. In the future both companies intend to conduct joint R&D activities for the development of AI-enabled imaging solutions.

Lord Drayson, CEO at Sensyne Health said: “Initiatives like this are essential to quickly maximise the opportunity AI presents to improve patient care and accelerate medical research. I’m delighted to be working with Bayer, extending our partnership to deliver the benefits of digital innovation directly to clinicians and patients.”

The new hub itself is located in Reading’s Green park – at the heart of the Thames Valley –which boasts more than 45,000 tech-related jobs and contributes around £12 billion to the UK’s annual digital technology revenues.

The UK currently stands as the world’s third largest market for AI investment, following the US and China with funding rising six-fold since 2014.

Nik Kiran

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches